Quantitation of a new hypoglycaemic drug, 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (DG-5128), in plasma by gas chromatography-mass spectrometry.
D000818:Animals; D001711:Biotransformation; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007004:Hypoglycemic Agents / Q000097:blood*; D007093:Imidazoles / Q000097:blood*; D007202:Indicators and Reagents; D009682:Magnetic Resonance Spectroscopy; D051381:Rats; D013045:Species Specificity; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet
D007004:Hypoglycemic Agents; D007093:Imidazoles; D007202:Indicators and Reagents; C032368:midaglizole